Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
2002 4
2003 1
2004 2
2005 1
2006 1
2007 2
2008 2
2009 5
2010 12
2011 12
2012 11
2013 9
2014 17
2015 13
2016 13
2017 13
2018 18
2019 22
2020 37
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 30287433

177 results
Results by year
Filters applied: . Clear all
Page 1
What is the significance of monoclonal gammopathy of undetermined significance?
Atkin C, Richter A, Sapey E. Atkin C, et al. Clin Med (Lond). 2018 Oct;18(5):391-396. doi: 10.7861/clinmedicine.18-5-391. Clin Med (Lond). 2018. PMID: 30287433 Free PMC article. Review.
[Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A, Czarkowska-Paczek B. Stelmach-Gołdyś A, et al. Przegl Lek. 2012;69(5):194-6. Przegl Lek. 2012. PMID: 23050415 Review. Polish.
Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K. Viera S, et al. Klin Onkol. 2018 Summer;31(4):270-276. doi: 10.14735/amko2018270. Klin Onkol. 2018. PMID: 30541309 Review. English.
[Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S. Adam Z, et al. Vnitr Lek. 2014 Oct;60(10):861-79. Vnitr Lek. 2014. PMID: 25382009 Review. Czech.
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV. Dispenzieri A, et al. Lancet. 2010 May 15;375(9727):1721-8. doi: 10.1016/S0140-6736(10)60482-5. Lancet. 2010. PMID: 20472173 Free PMC article.
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, Björkholm M, Landgren O, Kristinsson SY. Sigurdardottir EE, et al. JAMA Oncol. 2015 May;1(2):168-74. doi: 10.1001/jamaoncol.2015.23. JAMA Oncol. 2015. PMID: 26181017
Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Kyle RA, Rajkumar SV. Kyle RA, et al. Oncology (Williston Park). 2011 Jun;25(7):578-86. Oncology (Williston Park). 2011. PMID: 21888255 Free PMC article. Review.
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N. Naina HV, et al. Am J Nephrol. 2012;35(4):365-71. doi: 10.1159/000337482. Epub 2012 Apr 2. Am J Nephrol. 2012. PMID: 22473253
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW, Mutis T, Poddighe PJ, Lokhorst HM, Zweegman S. van de Donk NW, et al. Int J Lab Hematol. 2016 May;38 Suppl 1:110-22. doi: 10.1111/ijlh.12504. Epub 2016 May 9. Int J Lab Hematol. 2016. PMID: 27161311 Review.
Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies.
Altrock PM, Ferlic J, Galla T, Tomasson MH, Michor F. Altrock PM, et al. JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00131. JCO Clin Cancer Inform. 2018. PMID: 30652561 Free PMC article.
177 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback